Wellington Management Group LLP acquired a new stake in shares of Afya Limited (NASDAQ:AFYA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 52,203 shares of the company's stock, valued at approximately $829,000. Wellington Management Group LLP owned 0.06% of Afya as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of the business. State Street Corp boosted its position in Afya by 118.2% in the 3rd quarter. State Street Corp now owns 73,098 shares of the company's stock valued at $1,248,000 after buying an additional 39,592 shares during the period. Teacher Retirement System of Texas purchased a new position in Afya during the 4th quarter worth $329,000. Lifestyle Asset Management Inc. lifted its holdings in shares of Afya by 5.5% in the 4th quarter. Lifestyle Asset Management Inc. now owns 17,682 shares of the company's stock worth $281,000 after buying an additional 929 shares during the period. Van ECK Associates Corp raised its holdings in shares of Afya by 41.9% in the fourth quarter. Van ECK Associates Corp now owns 9,677 shares of the company's stock valued at $154,000 after acquiring an additional 2,856 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in Afya by 2,115.9% in the fourth quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company's stock worth $106,000 after acquiring an additional 6,369 shares during the period. Institutional investors own 88.02% of the company's stock.
Afya Stock Down 0.2 %
Shares of Afya stock traded down $0.03 on Tuesday, reaching $17.93. The stock had a trading volume of 50,021 shares, compared to its average volume of 121,700. Afya Limited has a 1 year low of $14.52 and a 1 year high of $20.06. The company has a 50 day moving average price of $17.33 and a 200 day moving average price of $16.64. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $1.68 billion, a P/E ratio of 14.46, a P/E/G ratio of 0.29 and a beta of 0.66.
Afya Announces Dividend
The firm also recently declared a -- dividend, which was paid on Friday, April 4th. Stockholders of record on Wednesday, March 26th were given a dividend of $0.232 per share. The ex-dividend date was Wednesday, March 26th. Afya's payout ratio is presently 17.69%.
Analyst Ratings Changes
A number of research analysts have commented on the stock. Citigroup reissued a "sell" rating and set a $15.00 target price (down previously from $18.00) on shares of Afya in a research report on Friday, January 31st. JPMorgan Chase & Co. reduced their price objective on shares of Afya from $25.00 to $20.50 and set a "neutral" rating for the company in a research note on Friday, January 17th. Finally, Morgan Stanley cut Afya from an "equal weight" rating to an "underweight" rating and dropped their target price for the company from $19.00 to $17.00 in a research report on Tuesday, March 11th. Three research analysts have rated the stock with a sell rating and two have given a hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Reduce" and a consensus target price of $17.60.
Get Our Latest Report on AFYA
Afya Company Profile
(
Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Articles

Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.